Table 1.
Study | Study Design | Region | No. of Subjects | Mean Age (y) | % Male | Method and Time of Assessment | Prevalence*(%) |
---|---|---|---|---|---|---|---|
Structured Interviews | |||||||
Schleifer et al., 198933 | Prosp. cohort | United States | 283 | 64 | 64 | RDC; 8 to 10 d post-AMI | Major=18, Minor=27 |
Carney et al., 199034 | Cross-sectional | United States | 70 | 53 | 76 | DIS; in hospital 5 to 7 d post-AMI | 23 |
Forrester et al., 199235 | Cross-sectional | United States | 129 | 59 | 74 | PSE; in hospital within 10 d of AMI | 21 |
Lesperance et al., 199636† | Prosp. cohort | Canada | 222 | 60 | 78 | DIS in hospital 5 to 15 d post-AMI | 16 |
Kaufmann et al., 19998 | Prosp. cohort | United States | 331 | 56% >65 y | 66 | DIS; in hospital 3 to 15 d post-AMI | 27 |
Bush et al., 20016 | Prosp. cohort | United States | 267 | 65 | 58 | SCID; in hospital within 2 to 5 d of AMI | 17 |
Watkins et al., 200237 | Cross-sectional | United States | 204 | 59 | 58 | DIS; in hospital 3 to 9 d post-AMI | 18 |
Berkman et al., 200338 | RCT | United States | 9,279 | 63 | 61 | DISH; 2 to 4 wk post-AMI | 20 |
Weighted/unweighted means | 61/60 | 62/67 | 19.8/20.2 | ||||
BDI ≥10 | |||||||
Bush et al., 20016 | Prosp. cohort | United States | 267 | 65 | 58 | BDI≥ 10; in hospital within 2 to 5 d of AMI | 20 |
Lane et al., 200239 | Prosp. cohort | Europe | 288 | 63 | 75 | BDI≥ 10; in hospital within 15 d of AMI | 30 |
Lesperance et al., 20023 | Prosp. cohort | Canada | 896 | 59 | 68 | BDI≥ 10; in hospital | 32 |
Luutonen et al., 200240 | Prosp. cohort | Europe | 85 | 61 | 77 | BDI≥ 10; in hospital | 21 |
Barefoot et al., 200341 | Prosp. cohort | United States | 187 | 61 | 63 | HAM-D, BDI≥ 10; 2 wk post-AMI | 28, 37 |
Lauzon et al., 200342 | Prosp. cohort | Canada | 550 | 60 | 79 | BDI≥ 10; within 2 to 3 d of hospitalization | 35 |
Weighted/unweighted means | 61/61 | 70/70 | 31.1/29.2 | ||||
HADS ≥8, ≥11 | |||||||
O'Rourke and Hampson 199925 | Prosp. cohort | Europe | 70 | 58 | 74 | HADS ≥8; 3 to 5 d post-AMI | 14 |
Mayou et al., 200027 | Prosp. cohort | Europe | 344 | 63 | 73 | HADS≥ 8, ≥11; in hospital within 3 d AMI | 17, 8 |
Brink et al., 200228 | Prosp. cohort | Europe | 114 | 68 | 68 | HADS ≥8, ≥11; in hospital within 1 wk AMI | 11, 8 |
Martin et al., 200329 | Prosp. cohort | Europe | 335 | 67 | 67 | HADS ≥8, ≥11; in hospital within 1 wk AMI | 15, 6 |
Bennett and Mayfield, 198826 | Prosp. cohort | Europe | 37 | 62 | 73 | HADS≥ 11; in hospital | 13 |
Weighted/unweighted means for HADS ≥8 | 65/64 | 70/71 | 15.5 / 14.6 | ||||
Weighted/unweighted means for HADS ≥11 | 65/65 | 70/70 | 7.3/ 8.8 | ||||
Other Assessment Tools and Criteria | |||||||
Taylor et al., 198643 | RCT | United States | 173 | 52 | 100 | HAM-D; within 3 wk of AMI | 13 |
Davis and Jensen 198844 | Prosp. cohort | Canada | 52 | 51 | 90 | BDI≥ 13; in hospital | 10 |
Silverstone 199045 | Prosp. cohort | Europe | 100 | NR | NR | Montgomery-Asberg; in hospital | 19 |
Gilutz et al., 199146 | Prosp. cohort | Europe, Israel | Europe=98 Israel=87 | NR | NR | Holland Sgroi Anxiety Depression Scale; in hospital 10 to 15 d post-AMI | 31, 35 |
Legault et al., 199247 | Prosp. cohort | Canada | 52 | 55 | 78 | BDI≥ 16; in hospital | 18 |
Steeds et al., 200448 | Prosp. cohort | Europe | 131 | NR | NR | BDI-II ≥ 12; in hospital | 47 |
See text.
Subset of Lesperance, 2002.
Prosp. Cohort, Prospective cohort study; RDC, Research Diagnostic Criteria; DIS, Diagnostic Interview Schedule; PSE, Present State Examination; BDI, Beck Depression Inventory; RCT, Randomized Controlled Trial; DISH, Depression Interview and Structured Hamilton; SCID, Structured Clinical Interview for DSM; NR, Not Reported; HAM-D, Hamilton Rating Scale for Depression; HADS, Hospital Anxiety and Depression Scale.